Navigation Links
‘Gypsies' and Travellers' Health Much Worse Than Other Vulnerable Group

The health of Gypsies and Travellers is significantly worse than that of other vulnerable groups, reveals research in the Journal of Epidemiology and Community Health.//

It is not known how many Gypsies and Travellers there are in Britain, but estimates put the number at around 300,000.

The researchers assessed the health of just under 300 Gypsies and Travellers of UK and Irish origin in five locations across England (Sheffield, Leicester, Norfolk, London, and Bristol).

Using validated measures, this was compared with the health of people living in rural communities, or areas of deprivation, or ethnic minority communities, all of whom tend to have poorer health than average.

The findings showed that Gypsies and Travellers were significantly more likely to have a long term illness, problem, or disability that interfered with daily life or which limited their ability to work.

They were also more immobile, had greater problems maintaining their own health, and endured more pain and discomfort, anxiety and depression than people in the other groups.

Their rates of diabetes, stroke and cancer were not higher. But the authors point out that often these diseases can be 'silent' and that any associated symptoms might not have been recognised.

Gypsies and Travellers were also significantly more likely to say they had chest pain, respiratory problems, and arthritis. And they reported higher rates of miscarriage and premature death among their children.

Policies to tackle health inequalities have clearly not been meeting the needs of Gypsies and Travellers, conclude the authors.

A companion paper in the journal, which looked at Gypsies' and Travellers' health beliefs and experiences, found that ill health is seen as 'normal' and something that everyone has to bear.

Source-Eurekalert
'"/>




Page: 1

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...ia Medical School presented their study that shows...tic neuropathy, or nerve damage.Topiramate (Topama...t research shows it can also promote significant w...2 diabetes, the drug showed evidence of improving ...
...p the hearts of children with diabetes. Researcher...indings over the weekend at the American Diabetes ...ding to the American Diabetes Association, people ...likely to have heart disease as compared to those ...
...s to numerous health concerns. But a new study fin...ink weight to athletic performance and appearance ...s also fail to see the importance of a healthy wei...n children more in terms of appearance and self-es...
... can have a serious impact on their health and qua... Educators (AADE) says about a third of the estima...sis, the most common type of nail fungus. Because ...ced ability to fight infection, people with diabet...
Other Medicine News:
(Date:10/10/2008)...ire-FirstCall/ -- Boston Scientific,Corporation (N...mpany,s major,events and press announcements at th...ieth annual Transcatheter Cardiovascular Therapeut...tober 12 to 17 in Washington, D.C., Boston Scient...,efficacy data on its TAXUS(R) Express2(TM) and se...
(Date:10/9/2008)...ted in November 2008, BOTHELL, Wash., Oct. 9 /PRN...DD ) announced today the completion of patient enr...tal trials to evaluate the safety and,efficacy of ...buprofen for,the over-the-counter (OTC) market. Th...this pivotal trial in November 2008. Ibuprofen is ...
(Date:10/8/2008)...reatments for Spinal Cord, Other Nerve,Injuries -,...A protein that enables,nerve cells to communicate ...e developing nervous system. Research into how tha...nerve cells may provide a basis for eventual,treat...rvous system,including spinal cord injury., "Thi...
(Date:10/8/2008)...of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct. ...als,Corporation (TSX: NVN) today presented positiv...ary Toll-like Receptor 3 agonist, Poly IC-Poly,Arg...08 in Lyon, France.,Study results demonstrated Pol...e Toll-like Receptor 3 (TLR3) pathway. Data showed...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5SXC Health Solutions to present at Raymond James 29th Annual Institutional Investors Conference 12344 1Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 1Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 2Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 3Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 4Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 5Millennium Expands VELCADE 28R 29 28Bortezomib 29 For Injection Program In Non Hodgkins Lymphoma 1396 6Hooper Holmes Updates Guidance 12337 1Hooper Holmes Updates Guidance 12337 2Hooper Holmes Updates Guidance 12337 3Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration 3420 1Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration 3420 2
...d, April 27, 2007 –,Merck Serono S.A. (virt-....A. (SWX: NWRN) announced today that Professor,Fab...f the first,Phase III trial of safinamide as an ad...rly Parkinson’s disease (PD),patients at the...,to be held in Boston from 28 April to 5 May 2007....
...il 30. 2007-- Scientific evidence,increasingly lin...ized particles -- so small that some scientists qu... play a viable role in,causing disease. , ,A new M...ce of,nanoparticles near plaque-filled arteries in...les potentially represent a,previously unrecognize...
Other Medicine Technology:Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 2Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 3Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 4Evidence of Nanoparticles Found in Plaque-Filled Arteries 2
...the rapid, detection of platelet dysfunction. It i... that uniquely simulates the in vivo function of p...s platelet function under high shear conditions si...lood vessel. Testing is performed using a small wh...
...rming erythrocyte sedimentation rate (ESR) tests u...es-matic System DIESSE brings to the clinical diag... which addresses and resolves every technical limi...e.,By means of a fully automated analyzer and a es...
...n rate analysers, which are especially user-friend...stablished advantages of the existing analysers wi...rantee time-saving standardised analysis of the er...s an essential aspect of daily recurrent routine a...
Blood sedimentation rate analysis
Medicine Products: